| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 2.81e-05 | 5 | 34 | 2 | GO:0140444 | |
| GeneOntologyBiologicalProcess | centrosome localization | 2.36e-05 | 35 | 33 | 3 | GO:0051642 | |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 2.57e-05 | 36 | 33 | 3 | GO:0061842 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 1.40e-04 | 11 | 34 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 1.40e-04 | 11 | 34 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 1.40e-04 | 11 | 34 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 1.40e-04 | 11 | 34 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | outer kinetochore | 6.93e-04 | 24 | 34 | 2 | GO:0000940 | |
| HumanPheno | Ichthyosis | 1.94e-06 | 144 | 9 | 5 | HP:0008064 | |
| HumanPheno | Abnormal muscle fiber emerin | 4.15e-05 | 6 | 9 | 2 | HP:0030116 | |
| HumanPheno | Absent muscle fiber emerin | 4.15e-05 | 6 | 9 | 2 | HP:0030117 | |
| HumanPheno | Hypertriglyceridemia | 5.36e-05 | 135 | 9 | 4 | HP:0002155 | |
| HumanPheno | Decreased cervical spine flexion due to contractures of posterior cervical muscles | 5.80e-05 | 7 | 9 | 2 | HP:0004631 | |
| HumanPheno | Abnormality of the voice | 9.24e-05 | 545 | 9 | 6 | HP:0001608 | |
| HumanPheno | Acantholysis | 1.24e-04 | 10 | 9 | 2 | HP:0100792 | |
| HumanPheno | Ventricular escape rhythm | 1.51e-04 | 11 | 9 | 2 | HP:0005155 | |
| HumanPheno | Hyperlipidemia | 1.51e-04 | 176 | 9 | 4 | HP:0003077 | |
| HumanPheno | Proximal upper limb amyotrophy | 2.14e-04 | 13 | 9 | 2 | HP:0008948 | |
| HumanPheno | Epidermal thickening | 2.18e-04 | 379 | 9 | 5 | HP:0011368 | |
| HumanPheno | Abnormality of the musculature of the upper arm | 2.50e-04 | 14 | 9 | 2 | HP:0001457 | |
| HumanPheno | Abnormality of the larynx | 2.89e-04 | 666 | 9 | 6 | HP:0001600 | |
| HumanPheno | Limb-girdle muscular dystrophy | 3.72e-04 | 17 | 9 | 2 | HP:0006785 | |
| HumanPheno | Thickened skin | 4.01e-04 | 431 | 9 | 5 | HP:0001072 | |
| HumanPheno | Type 1 muscle fiber atrophy | 4.18e-04 | 18 | 9 | 2 | HP:0011807 | |
| HumanPheno | Abnormality of lipoprotein cholesterol concentration | 5.02e-04 | 96 | 9 | 3 | HP:0010979 | |
| HumanPheno | Proximal lower limb amyotrophy | 5.19e-04 | 20 | 9 | 2 | HP:0008956 | |
| HumanPheno | Abnormality of the upper respiratory tract | 5.47e-04 | 1111 | 9 | 7 | HP:0002087 | |
| HumanPheno | Abnormality thigh musculature morphology | 5.73e-04 | 21 | 9 | 2 | HP:0001441 | |
| HumanPheno | Sudden cardiac death | 7.89e-04 | 112 | 9 | 3 | HP:0001645 | |
| HumanPheno | Intellectual disability, borderline | 8.15e-04 | 25 | 9 | 2 | HP:0006889 | |
| Domain | Spectrin_repeat | 1.43e-07 | 29 | 31 | 4 | IPR002017 | |
| Domain | Spectrin | 7.17e-06 | 23 | 31 | 3 | PF00435 | |
| Domain | KASH | 1.60e-05 | 4 | 31 | 2 | PF10541 | |
| Domain | KASH | 1.60e-05 | 4 | 31 | 2 | IPR012315 | |
| Domain | KASH | 1.60e-05 | 4 | 31 | 2 | SM01249 | |
| Domain | KASH | 1.60e-05 | 4 | 31 | 2 | PS51049 | |
| Domain | Spectrin/alpha-actinin | 1.99e-05 | 32 | 31 | 3 | IPR018159 | |
| Domain | SPEC | 1.99e-05 | 32 | 31 | 3 | SM00150 | |
| Domain | CH | 1.69e-04 | 65 | 31 | 3 | SM00033 | |
| Domain | CH | 2.10e-04 | 70 | 31 | 3 | PF00307 | |
| Domain | - | 2.19e-04 | 71 | 31 | 3 | 1.10.418.10 | |
| Domain | CH | 2.38e-04 | 73 | 31 | 3 | PS50021 | |
| Domain | CH-domain | 2.58e-04 | 75 | 31 | 3 | IPR001715 | |
| Domain | Actinin_actin-bd_CS | 6.60e-04 | 23 | 31 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 6.60e-04 | 23 | 31 | 2 | PS00020 | |
| Domain | ACTININ_1 | 6.60e-04 | 23 | 31 | 2 | PS00019 | |
| Domain | GDS_CDC24_CS | 1.90e-03 | 39 | 31 | 2 | IPR001331 | |
| Domain | DH_1 | 4.89e-03 | 63 | 31 | 2 | PS00741 | |
| Domain | RhoGEF | 5.67e-03 | 68 | 31 | 2 | SM00325 | |
| Domain | DH_2 | 6.00e-03 | 70 | 31 | 2 | PS50010 | |
| Domain | RhoGEF | 6.00e-03 | 70 | 31 | 2 | PF00621 | |
| Domain | DH-domain | 6.17e-03 | 71 | 31 | 2 | IPR000219 | |
| Domain | - | 6.17e-03 | 71 | 31 | 2 | 1.20.900.10 | |
| Domain | WD40 | 8.90e-03 | 259 | 31 | 3 | PF00400 | |
| Domain | SH3_2 | 8.94e-03 | 86 | 31 | 2 | IPR011511 | |
| Domain | SH3_2 | 8.94e-03 | 86 | 31 | 2 | PF07653 | |
| Domain | WD40 | 9.76e-03 | 268 | 31 | 3 | SM00320 | |
| Domain | WD40_repeat | 1.02e-02 | 272 | 31 | 3 | IPR001680 | |
| Domain | WD_REPEATS_1 | 1.08e-02 | 278 | 31 | 3 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.09e-02 | 279 | 31 | 3 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.09e-02 | 279 | 31 | 3 | PS50294 | |
| Domain | WD40_repeat_dom | 1.29e-02 | 297 | 31 | 3 | IPR017986 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | 1.24e-04 | 10 | 24 | 2 | MM14956 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | 1.51e-04 | 11 | 24 | 2 | M9990 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ORGANIZATION_OF_THE_OUTER_KINETOCHORE | 4.67e-04 | 19 | 24 | 2 | M47885 | |
| Pubmed | Scrib:Rac1 interactions are required for the morphogenesis of the ventricular myocardium. | 7.54e-07 | 18 | 35 | 3 | 25139745 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 22768332 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 17761684 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 31578382 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 11792814 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 9.84e-07 | 2 | 35 | 2 | 24931616 | |
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 9.84e-07 | 2 | 35 | 2 | 17267447 | |
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 9.84e-07 | 2 | 35 | 2 | 24718612 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 24586179 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 17462627 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 10878022 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 33472039 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 27519653 | ||
| Pubmed | Nesprins anchor kinesin-1 motors to the nucleus to drive nuclear distribution in muscle cells. | 2.95e-06 | 3 | 35 | 2 | 25516977 | |
| Pubmed | The inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope. | 2.95e-06 | 3 | 35 | 2 | 16079285 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 12408964 | ||
| Pubmed | 3.00e-06 | 225 | 35 | 5 | 12168954 | ||
| Pubmed | 4.07e-06 | 963 | 35 | 8 | 28671696 | ||
| Pubmed | Genome-wide association analysis identifies 13 new risk loci for schizophrenia. | 4.43e-06 | 109 | 35 | 4 | 23974872 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 19596800 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 16648470 | ||
| Pubmed | LINC complexes mediate the positioning of cone photoreceptor nuclei in mouse retina. | 5.90e-06 | 4 | 35 | 2 | 23071752 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 8950514 | ||
| Pubmed | Outer nuclear membrane protein Kuduk modulates the LINC complex and nuclear envelope architecture. | 5.90e-06 | 4 | 35 | 2 | 28716842 | |
| Pubmed | STEF/TIAM2-mediated Rac1 activity at the nuclear envelope regulates the perinuclear actin cap. | 5.90e-06 | 4 | 35 | 2 | 29844364 | |
| Pubmed | Nesprins, but not sun proteins, switch isoforms at the nuclear envelope during muscle development. | 5.90e-06 | 4 | 35 | 2 | 20108321 | |
| Pubmed | 9.39e-06 | 1442 | 35 | 9 | 35575683 | ||
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 18396275 | ||
| Pubmed | LINC complexes form by binding of three KASH peptides to domain interfaces of trimeric SUN proteins. | 9.82e-06 | 5 | 35 | 2 | 22632968 | |
| Pubmed | Biological insights from 108 schizophrenia-associated genetic loci. | 1.27e-05 | 303 | 35 | 5 | 25056061 | |
| Pubmed | Structural Analysis of Different LINC Complexes Reveals Distinct Binding Modes. | 1.47e-05 | 6 | 35 | 2 | 33058875 | |
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 18827015 | ||
| Pubmed | Hes1 regulates corneal development and the function of corneal epithelial stem/progenitor cells. | 2.06e-05 | 7 | 35 | 2 | 18292208 | |
| Pubmed | 2.06e-05 | 7 | 35 | 2 | 27881301 | ||
| Pubmed | 2.06e-05 | 335 | 35 | 5 | 15741177 | ||
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 20093627 | ||
| Pubmed | Modular assembly of RWD domains on the Mis12 complex underlies outer kinetochore organization. | 4.40e-05 | 10 | 35 | 2 | 24530301 | |
| Pubmed | Nesprin 1α2 is essential for mouse postnatal viability and nuclear positioning in skeletal muscle. | 4.40e-05 | 10 | 35 | 2 | 28533284 | |
| Pubmed | 4.40e-05 | 10 | 35 | 2 | 16543498 | ||
| Pubmed | Nuclear membrane proteins with potential disease links found by subtractive proteomics. | 4.40e-05 | 10 | 35 | 2 | 12958361 | |
| Pubmed | A blueprint for kinetochores - new insights into the molecular mechanics of cell division. | 4.40e-05 | 10 | 35 | 2 | 21633384 | |
| Pubmed | 4.40e-05 | 10 | 35 | 2 | 15371340 | ||
| Pubmed | 4.40e-05 | 10 | 35 | 2 | 21199919 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 5.02e-05 | 202 | 35 | 4 | 33005030 | |
| Pubmed | The KMN protein network--chief conductors of the kinetochore orchestra. | 5.38e-05 | 11 | 35 | 2 | 23418356 | |
| Pubmed | 5.38e-05 | 11 | 35 | 2 | 22826121 | ||
| Pubmed | 5.38e-05 | 11 | 35 | 2 | 21038445 | ||
| Pubmed | 6.45e-05 | 12 | 35 | 2 | 15502821 | ||
| Pubmed | 7.62e-05 | 13 | 35 | 2 | 21177258 | ||
| Pubmed | 7.62e-05 | 13 | 35 | 2 | 8999895 | ||
| Pubmed | 8.89e-05 | 14 | 35 | 2 | 19874786 | ||
| Pubmed | MEK kinase 1 regulates c-Jun phosphorylation in the control of corneal morphogenesis. | 8.89e-05 | 14 | 35 | 2 | 14627958 | |
| Pubmed | Periderm prevents pathological epithelial adhesions during embryogenesis. | 1.02e-04 | 15 | 35 | 2 | 25133425 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 1.30e-04 | 1155 | 35 | 7 | 20360068 | |
| Pubmed | 1.33e-04 | 17 | 35 | 2 | 11781569 | ||
| Pubmed | 1.66e-04 | 19 | 35 | 2 | 22267201 | ||
| Pubmed | 2.11e-04 | 549 | 35 | 5 | 38280479 | ||
| Pubmed | 2.24e-04 | 22 | 35 | 2 | 12812986 | ||
| Pubmed | 2.46e-04 | 23 | 35 | 2 | 18809908 | ||
| Pubmed | 2.46e-04 | 23 | 35 | 2 | 16637659 | ||
| Pubmed | 2.46e-04 | 23 | 35 | 2 | 19841136 | ||
| Pubmed | 2.91e-04 | 25 | 35 | 2 | 23132931 | ||
| Pubmed | 2.91e-04 | 25 | 35 | 2 | 31410202 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 4.49e-04 | 1415 | 35 | 7 | 28515276 | |
| Pubmed | 4.68e-04 | 653 | 35 | 5 | 22586326 | ||
| Pubmed | Lem2 is essential for cardiac development by maintaining nuclear integrity. | 4.79e-04 | 32 | 35 | 2 | 37067297 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 5.02e-04 | 1024 | 35 | 6 | 24711643 | |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 5.35e-04 | 375 | 35 | 4 | 32788342 | |
| Pubmed | 5.70e-04 | 1049 | 35 | 6 | 27880917 | ||
| Pubmed | Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis. | 6.76e-04 | 38 | 35 | 2 | 11756498 | |
| Pubmed | 7.04e-04 | 173 | 35 | 3 | 23979707 | ||
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | 8.17e-04 | 1124 | 35 | 6 | 21900206 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 8.42e-04 | 184 | 35 | 3 | 32908313 | |
| Pubmed | 8.66e-04 | 43 | 35 | 2 | 12376548 | ||
| Pubmed | 9.90e-04 | 46 | 35 | 2 | 34265304 | ||
| Pubmed | 9.90e-04 | 46 | 35 | 2 | 25209997 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 1.00e-03 | 444 | 35 | 4 | 34795231 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.01e-03 | 774 | 35 | 5 | 15302935 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p11 | 6.11e-03 | 153 | 35 | 2 | chr11p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q25 | 6.98e-03 | 164 | 35 | 2 | chr6q25 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 7.70e-06 | 4 | 21 | 2 | 1252 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.64e-03 | 66 | 21 | 2 | 722 | |
| GeneFamily | WD repeat domain containing | 3.30e-03 | 262 | 21 | 3 | 362 | |
| GeneFamily | PDZ domain containing | 1.33e-02 | 152 | 21 | 2 | 1220 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.35e-02 | 206 | 21 | 2 | 682 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP | 1.27e-04 | 194 | 35 | 4 | M7467 | |
| Coexpression | GSE3982_MAC_VS_NKCELL_DN | 1.38e-04 | 198 | 35 | 4 | M5509 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP | 1.40e-04 | 199 | 35 | 4 | M9410 | |
| Coexpression | GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_DN | 1.43e-04 | 200 | 35 | 4 | M6396 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN | 1.43e-04 | 200 | 35 | 4 | M8618 | |
| Coexpression | GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_DN | 1.43e-04 | 200 | 35 | 4 | M5996 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_UP | 1.43e-04 | 200 | 35 | 4 | M3976 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 4.58e-07 | 198 | 35 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | severe-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.58e-07 | 198 | 35 | 5 | 4935b40fc848037a06055f30d90bde940b9d5321 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 4.69e-07 | 199 | 35 | 5 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-dn_T|COVID-19_Severe / Disease, condition lineage and cell class | 4.81e-07 | 200 | 35 | 5 | d01aa5fccada22f97d8350ad5888df2aadb5bb1c | |
| ToppCell | COVID-19_Severe-multiplets|COVID-19_Severe / disease group, cell group and cell class | 6.04e-06 | 152 | 35 | 4 | 451745151322c2fcea22dbb3dba681e12634a510 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.18e-05 | 180 | 35 | 4 | 6bb9f41c3a99d1bbe697f589fb2bcea9b7bfbeee | |
| ToppCell | Control-Lymphoid-Tregs|Control / Condition, Lineage and Cell class | 1.34e-05 | 186 | 35 | 4 | 6144f32a370594e45b91da142b4f435370c69b9a | |
| ToppCell | MS-Treg-CD4_Treg|MS / Condition, Cell_class and T cell subcluster | 1.43e-05 | 189 | 35 | 4 | b1310eed6113b3536868340a5b2b2587ad377fa9 | |
| ToppCell | MS-Treg|MS / Condition, Cell_class and T cell subcluster | 1.43e-05 | 189 | 35 | 4 | 3fa79242fb3dba4a3f52276da0124ba260423fb6 | |
| ToppCell | ILEUM-inflamed-(1)_Tregs|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.52e-05 | 192 | 35 | 4 | 1fe3417dfd1cf1758fd82c9ac13dbd88bdf0b548 | |
| ToppCell | IIH-CD8-CD8_1|IIH / Condition, Cell_class and T cell subcluster | 1.55e-05 | 193 | 35 | 4 | c5a4926003906d6726155f19061b73fb45d9962c | |
| ToppCell | CD8+_Memory_T_cell-CV-0|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.55e-05 | 193 | 35 | 4 | 995781d87a919c0380750878bafe584342bb83ad | |
| ToppCell | COVID-19-Lymphoid-Tregs|COVID-19 / Condition, Lineage and Cell class | 1.61e-05 | 195 | 35 | 4 | 284cfff4d59ecc1430997b118de17fee167dcbb1 | |
| ToppCell | COVID-19-Lymphoid-Tregs|Lymphoid / Condition, Lineage and Cell class | 1.61e-05 | 195 | 35 | 4 | 9ad844d9d5aac39d133ae8ab9c4839300f08064c | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 1.65e-05 | 196 | 35 | 4 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-NK_cell-NK|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.68e-05 | 197 | 35 | 4 | 48311c7d85ffabf59fd1685c31c18b3e84a145b5 | |
| ToppCell | Severe_COVID-19-T/NK-NK|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.68e-05 | 197 | 35 | 4 | cc20162892b59e48653981f91fc9a0c27064444d | |
| ToppCell | mild-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.68e-05 | 197 | 35 | 4 | 39800e6e83f2d333b753d121c7aeb2912b91faa2 | |
| ToppCell | T_cells-Treg_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.68e-05 | 197 | 35 | 4 | de5448fcdf4e433fc167496413abe5d0c8a5c6d8 | |
| ToppCell | Severe-Lymphoid-NK-NK|Severe / Condition, Lineage, Cell class and cell subclass | 1.68e-05 | 197 | 35 | 4 | d5b94f9f73e9d050245841b19b046242a32c6258 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-NK_cell-NK-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.68e-05 | 197 | 35 | 4 | a26dd66a6bd08b46657b3a7c41669e206a8887b3 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-NK_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.68e-05 | 197 | 35 | 4 | 92f35ea602489efd29ce3a8a186d1f70d65faf40 | |
| ToppCell | mild-dn_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.68e-05 | 197 | 35 | 4 | 07a1f59c83b748825e0708cd1cc7b63a2cb856cc | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.68e-05 | 197 | 35 | 4 | d4dfb3b561d0783cdbee4e8d27009ad81df695cb | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.68e-05 | 197 | 35 | 4 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | Severe-Lymphoid-NK|Severe / Condition, Lineage, Cell class and cell subclass | 1.71e-05 | 198 | 35 | 4 | 26b6d20527d22ce68067cdaea6b4330cb779f91b | |
| ToppCell | VE-CD8-CD8_1|VE / Condition, Cell_class and T cell subcluster | 1.71e-05 | 198 | 35 | 4 | 9747a486fddec917a3753651de0b2079ac2385ee | |
| ToppCell | severe-Treg|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.71e-05 | 198 | 35 | 4 | 377980b9f7d02818e1d145e6884604f8bfacc4f2 | |
| ToppCell | mild-Treg|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.71e-05 | 198 | 35 | 4 | 0269617c0628003d2a13dab98abfd2d15775d16a | |
| ToppCell | VE-CD8|VE / Condition, Cell_class and T cell subcluster | 1.75e-05 | 199 | 35 | 4 | 9ae4d3e93b6e0861258e567c901ec34f04ded547 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.75e-05 | 199 | 35 | 4 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.75e-05 | 199 | 35 | 4 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | Severe-Lymphoid|Severe / Condition, Lineage, Cell class and cell subclass | 1.75e-05 | 199 | 35 | 4 | 928e346b0f31d991ebab12fefb4eb9f4249e601d | |
| ToppCell | Severe-Lymphoid-T|Severe / Condition, Lineage, Cell class and cell subclass | 1.75e-05 | 199 | 35 | 4 | ad2be3739721b7bfc2bd50eafd01d4325b01016e | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-Treg|Leuk-UTI / Disease, condition lineage and cell class | 1.75e-05 | 199 | 35 | 4 | 100f45e04f284551b29ef0406476bdc347ddbf7e | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-05 | 200 | 35 | 4 | eda7a1d822e8663510662bc0ca34eaccc88d71ca | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.78e-05 | 200 | 35 | 4 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-dn_T|Control / Disease, condition lineage and cell class | 1.78e-05 | 200 | 35 | 4 | 10882c59b7aaf8bd4b5c00aa4ddbb9f7ac5b2cf5 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.44e-04 | 130 | 35 | 3 | d47d4ff1263815896470d854d25306eb36919e70 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.44e-04 | 130 | 35 | 3 | ad57b210c96caedadc1027b4d7a56b1bc389b137 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte-pericyte_E|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.61e-04 | 135 | 35 | 3 | 35928195cf34f055b353562c96f451aef2344d64 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.99e-04 | 145 | 35 | 3 | 734d85ca7a2e5e040f433cadc5f9be1f25cf2e91 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.99e-04 | 145 | 35 | 3 | 8ba09eb0fd27f25aa90a3ad75d67a9f79f3f4f43 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-Treg|ICU-SEP / Disease, Lineage and Cell Type | 1.99e-04 | 145 | 35 | 3 | ee99b58462f955b96d036aa67e343db047d66f64 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.99e-04 | 145 | 35 | 3 | 29422c908d58081e6a748e362a7ac41bf001444c | |
| ToppCell | E16.5-samps-Mesenchymal-Pericyte-pericyte_A|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.11e-04 | 148 | 35 | 3 | c87fe2373418ec0cfe37279003d1c4df4c0d0aac | |
| ToppCell | E16.5-samps-Mesenchymal-Pericyte|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.11e-04 | 148 | 35 | 3 | e697a7fb037873c9b11703d1bf836a69fc276e23 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.29e-04 | 152 | 35 | 3 | fc9472bc19f997103da535b035105f01429cb08e | |
| ToppCell | COVID-Treg-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster | 2.33e-04 | 153 | 35 | 3 | 47c649fd4231e507f2d4654ccac61faf21a04eff | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.33e-04 | 153 | 35 | 3 | 7480522a47e367f8facc4f5d599fbaf0b5ad4007 | |
| ToppCell | IIH-Treg|IIH / Condition, Cell_class and T cell subcluster | 2.33e-04 | 153 | 35 | 3 | 17704e18833812fcf2a2727b1e3f8a9984ba5b59 | |
| ToppCell | IIH-Treg-CD4_Treg|IIH / Condition, Cell_class and T cell subcluster | 2.38e-04 | 154 | 35 | 3 | d2211a892654b92decb208969040920f7ae8ba1e | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-dn_T|COVID-19_Severe / Disease group, lineage and cell class | 2.47e-04 | 156 | 35 | 3 | 83f25683e0f55472b56f915ee176fc05efc33a31 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Lung / Manually curated celltypes from each tissue | 2.47e-04 | 156 | 35 | 3 | 0ea6ca3f38109151a2a4fdf63a4f009929cdcc40 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.47e-04 | 156 | 35 | 3 | 53ded973358e3e48054130131e959f0d1f4ef60f | |
| ToppCell | COVID-Treg|COVID / Condition, Cell_class and T cell subcluster | 2.47e-04 | 156 | 35 | 3 | a1dd61d4c9ed8f283f0fcbf875c5fd7807ca370d | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic-Cycling_mono|Lung / Manually curated celltypes from each tissue | 2.47e-04 | 156 | 35 | 3 | 63b8cf14361b282872bc1c5b65d9fbc83e81a089 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.51e-04 | 157 | 35 | 3 | f1c6c313836352271033d23efd31b0f0a8a09e02 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-gdT|Leuk-UTI / Disease, Lineage and Cell Type | 2.56e-04 | 158 | 35 | 3 | c4b0af25608cee3d0d2b0193f5ff45d9dc87078b | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 158 | 35 | 3 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 158 | 35 | 3 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | Int-URO-Lymphocyte-T_NK-Treg|Int-URO / Disease, Lineage and Cell Type | 2.56e-04 | 158 | 35 | 3 | 457d64dceedb67bfff1303334cda1253a839b3d6 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.61e-04 | 159 | 35 | 3 | 6599707107083af6da092fe8984afc8fd89d2bb8 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.61e-04 | 159 | 35 | 3 | 916d070d099726f22deb71966efccff00f8ea071 | |
| ToppCell | Control-Treg|World / Disease group and Cell class | 2.71e-04 | 161 | 35 | 3 | ead9f5a491321f9e307f7c97e47a4ca124f59bb6 | |
| ToppCell | COVID-19_Severe-Treg|World / disease group, cell group and cell class | 2.71e-04 | 161 | 35 | 3 | c6eade2c60c572d823e6e81b5e8d47078671e9b0 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo|Lung / Manually curated celltypes from each tissue | 2.71e-04 | 161 | 35 | 3 | a1f10e04836848b1deaf295fae033f54d1572fcd | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.76e-04 | 162 | 35 | 3 | 19395bdb282b4a2d88cd33191af12c24a88c3d16 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-Treg|Multiple_Sclerosis / Disease, Lineage and Cell Type | 2.76e-04 | 162 | 35 | 3 | 975d52e3cc101e7592425128e1099d30847a8a42 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.91e-04 | 165 | 35 | 3 | 9ccce713d4122054bf4bef4a7126d90cf9141b84 | |
| ToppCell | Bac-SEP-Myeloid-tDC|Bac-SEP / Disease, Lineage and Cell Type | 2.91e-04 | 165 | 35 | 3 | 8728f927502e56f2768b4224e9111939d3d7815a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.91e-04 | 165 | 35 | 3 | dbe231d00843cae917efd1abea6079ace3b45cdf | |
| ToppCell | COVID-19_Moderate-Treg|COVID-19_Moderate / disease group, cell group and cell class | 3.01e-04 | 167 | 35 | 3 | 4ddb21421cbe72c06b61dd3a5eb1337e59de42e5 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.01e-04 | 167 | 35 | 3 | ded4d6cccd3660662f12cf5a512de31d26325f1b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.01e-04 | 167 | 35 | 3 | abc4ba308ca3be41b0da604f5d82579fd58dff7b | |
| ToppCell | mild_COVID-19-Treg|World / disease group, cell group and cell class (v2) | 3.01e-04 | 167 | 35 | 3 | 69330689b6e353c8ee9ea1b63a5eac6ab38d456f | |
| ToppCell | COVID-19_Moderate-Treg|World / disease group, cell group and cell class | 3.12e-04 | 169 | 35 | 3 | 27ad11239559b025bef582f89b2a83501d9d3993 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.12e-04 | 169 | 35 | 3 | f06118754fa62c580b4bcbecff6f9e5fdc2106a0 | |
| ToppCell | Severe-Lymphoid-T-|Severe / Condition, Lineage, Cell class and cell subclass | 3.17e-04 | 170 | 35 | 3 | 5788e1158fde036937d41708e9db3222ca351eb1 | |
| ToppCell | COVID-19_Severe-Treg|COVID-19_Severe / disease group, cell group and cell class | 3.17e-04 | 170 | 35 | 3 | d61269a51283125835884c4aa50623756c4fdda2 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Cytotoxic_CD8+_T|normal_Pleural_Fluid / Location, Cell class and cell subclass | 3.23e-04 | 171 | 35 | 3 | 6be81c20f4e962b414afcedfe478dd59c510d1e1 | |
| ToppCell | NS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.23e-04 | 171 | 35 | 3 | adda76991d9b150bb8ccf3989b7cbbf41843cf0b | |
| ToppCell | mild_COVID-19-Treg|mild_COVID-19 / disease group, cell group and cell class (v2) | 3.28e-04 | 172 | 35 | 3 | 77af6324c06b67867e7ce07706536fe38de5ed7b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.28e-04 | 172 | 35 | 3 | 86f52f486d67217fc1b8443ab362c975df2974a4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.28e-04 | 172 | 35 | 3 | fb2df8fea6df5947165f13978f1d1006d15b60fd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.28e-04 | 172 | 35 | 3 | e38ebb216e4ddcd008148fcbaf709b4f3c83706a | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-04 | 174 | 35 | 3 | 9d5dcd46cf346c381dea68ada6665f7fb68114a3 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-04 | 174 | 35 | 3 | 53cec5c666c45278a71c21dd9c62a052a97e0fdf | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-04 | 174 | 35 | 3 | ff13a5c55d18b951315908f33cb47c7f9cb901bf | |
| ToppCell | Healthy_donor-Treg|World / disease group, cell group and cell class (v2) | 3.40e-04 | 174 | 35 | 3 | dc3b06420b0ad9c7060571e7bf5714e028d598bf | |
| ToppCell | Healthy_donor-Treg|Healthy_donor / disease group, cell group and cell class (v2) | 3.40e-04 | 174 | 35 | 3 | 1d76921c8404b5be5fbe9f3157d53578033f2ad2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.45e-04 | 175 | 35 | 3 | 16c835e62a3321f6cf6163954889946bbb869498 | |
| ToppCell | T_cells-Tph_and_Tfh|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.51e-04 | 176 | 35 | 3 | 56c055488e34605d32562571a2fee621b47c9441 | |
| ToppCell | Healthy_Control-Lymphoid-T-Treg|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.51e-04 | 176 | 35 | 3 | 7765a5b04ac117d525201f8eb08e1754e55942ff | |
| ToppCell | (1)_T_regulatory|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.57e-04 | 177 | 35 | 3 | 5cda56b10df1ee8971ce8470d52062e01b703a4e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 178 | 35 | 3 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-Treg|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.63e-04 | 178 | 35 | 3 | e37142a84d9713ff1571ce9f976842bf5c17c86f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.69e-04 | 179 | 35 | 3 | 593fc323b28304a57ae162f64b0890b893fff446 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.69e-04 | 179 | 35 | 3 | 708fc0b8ffcb5fac43c52541acb6671fe1cfbb0d | |
| ToppCell | COPD-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 3.75e-04 | 180 | 35 | 3 | 51a12fbad5fa7bb12e6d616a02ff9b5141e2b063 | |
| Drug | plakin | 5.91e-06 | 82 | 33 | 4 | CID000018752 | |
| Drug | AC1L9LMC | 6.20e-06 | 83 | 33 | 4 | CID000448113 | |
| Drug | Prazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; HL60; HT_HG-U133A | 8.98e-06 | 197 | 33 | 5 | 3098_UP | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 7.72e-06 | 4 | 34 | 2 | cv:CN293514 | |
| Disease | vital capacity | 7.84e-06 | 1236 | 34 | 9 | EFO_0004312 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 1.29e-05 | 5 | 34 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 1.29e-05 | 5 | 34 | 2 | C0410190 | |
| Disease | Emery-Dreifuss muscular dystrophy | 1.93e-05 | 6 | 34 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 1.93e-05 | 6 | 34 | 2 | C0410189 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 2.70e-05 | 7 | 34 | 2 | C0751337 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 8.44e-05 | 12 | 34 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | ovulation | 2.18e-04 | 19 | 34 | 2 | GO_0030728 | |
| Disease | bipolar disorder (is_implicated_in) | 5.13e-04 | 29 | 34 | 2 | DOID:3312 (is_implicated_in) | |
| Disease | smoking status measurement, Cannabis use, schizophrenia | 5.13e-04 | 29 | 34 | 2 | EFO_0006527, EFO_0007585, MONDO_0005090 | |
| Disease | sphingolipid measurement | 9.78e-04 | 40 | 34 | 2 | EFO_0004622 | |
| Disease | Malignant neoplasm of breast | 1.29e-03 | 1074 | 34 | 6 | C0006142 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.46e-03 | 49 | 34 | 2 | DOID:0060037 (implicated_via_orthology) | |
| Disease | venous thromboembolism | 1.87e-03 | 460 | 34 | 4 | EFO_0004286 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NQNVDQILWKNAFYQ | 636 | Q86US8 | |
| WNSQAQIDQKLANQI | 336 | Q9NX77 | |
| NNNQDFQEWLEQLNR | 531 | Q15052 | |
| WIQNVSLKFQQHQQT | 51 | Q14667 | |
| FQEVQQTQALAWQAQ | 606 | Q9UJ55 | |
| QQNQVLQTKWELLQQ | 201 | P35908 | |
| TEQNFQLAKQIQSQW | 86 | Q04609 | |
| LQQNQSWTVKQQCVD | 146 | Q6ZVX7 | |
| IYKNWRRQQQQQQQQ | 66 | P0CG43 | |
| LQLQVQAQQQAWQAL | 176 | Q6P1K2 | |
| FKLLQNQIQQQTWTD | 796 | Q9UIQ6 | |
| VQFLNNAWGIQKKQN | 226 | Q9UMY1 | |
| WLMAQQQQELQQKEQ | 21 | A0A1B0GVQ3 | |
| SQVLQICQWDQQENQ | 246 | Q6ZP82 | |
| QQQQQQQQQKLSGWG | 976 | Q6Y7W6 | |
| EKQQIQNDLNQWKTQ | 1856 | P15924 | |
| QVKQLEQALQNNTQW | 86 | Q9Y264 | |
| VNKAAWQKTVNNNQQ | 2856 | Q99698 | |
| WQKTVNNNQQSLFQR | 2861 | Q99698 | |
| DQSQQLAVQQKQLWQ | 1366 | A3KN83 | |
| LCWDQSQNQVQVVLN | 356 | Q96GQ5 | |
| LQEKQNNQIWNIVQE | 321 | Q15542 | |
| LQQATEFNQWKNVVF | 226 | Q76EJ3 | |
| KQNLQKWQQFNSDLN | 8436 | Q8NF91 | |
| NQQCQNTVVLWENTK | 1506 | Q8WXH0 | |
| INWIQEENNNVNLSQ | 31 | Q9H9A7 | |
| VWQANQALQEYQQKD | 781 | Q9NTG1 | |
| QQEQLLKQQQQHQWQ | 651 | P48634 | |
| AFQNLVKQQEWVNQQ | 321 | Q9UKI8 | |
| KQQANEAFACQQWTQ | 366 | Q8N5D0 | |
| AVQNQWQLQQEKHLQ | 151 | O95229 | |
| KAIENQIQQWEQNLE | 671 | Q8IVF5 | |
| QVNWEQQDQLLAICN | 56 | Q495A1 | |
| LKEAIQQQQNQLVWV | 786 | Q07157 | |
| YLWKINQETQNNLNQ | 146 | A6NLI5 | |
| QNLNLIQDQNAQTRW | 156 | Q5FWF6 | |
| VYQQDWAQNNALQLQ | 1266 | Q12879 |